SCHEMBL7199849

SCHEMBL7199849

CC(O)C(O)CCn1cnc2c(S)nc(N)nc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE1 P24864 7/20 0.44
CDK2 P24941 7/20 0.44
CDK1 P06493 4/20 0.44
CCNB1 P14635 4/20 0.44
CYP2C19 P33261 2/20 0.41
SLC29A1 Q99808 2/20 0.40
PDGFRA P16234 1/20 0.38
TLR9 Q9NR96 2/20 0.38
TLR7 Q9NYK1 2/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
ADRA1A P35348 1/20 0.37
HSD17B10 Q99714 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5930324 0.83 CCNE1 (0.44) CCNE1CDK2CDK1CCNB1CYP2C19
SCHEMBL6744537 0.78 ADORA2A (0.55) CCNE1CDK2CDK1CCNB1CYP2C19
SCHEMBL10848639 0.76 KDM4E (0.61) CCNE1CDK2CDK1CCNB1CYP2C19
SCHEMBL8493219 0.74 TK1 (0.64) ALDH1A1HSD17B10CYP3A4HIF1A
SCHEMBL9388321 0.72 CYP2C19 (0.47) CCNE1CDK2CDK1CCNB1CYP2C19
SCHEMBL17226007 0.72 CDK1 (0.55) CCNE1CDK2CDK1CCNB1ADORA2A
SCHEMBL7272071 0.71 CCNE1 (0.43) CCNE1CDK2CDK1CCNB1CYP2C19
SCHEMBL7272082 0.71 CCNE1 (0.43) CCNE1CDK2CDK1CCNB1CYP2C19
SCHEMBL7057757 0.71 CCNE1 (0.45) CCNE1CDK2CDK1CCNB1CYP2C19
SCHEMBL7262136 0.70 CYP3A4 (0.64) CCNE1CDK2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6573378-B1 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine having a purity of greater than 95% by weight or it's sodium salt NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2003-06-03 US disclosed
US-5075445-A GUANINE DERIVATIVES BEECHAM GROUP P.L.C. (GB) 1991-12-24 US disclosed
EP-0141927-A2 Antiviral guanine derivatives BEECHAM GROUP PLC (GB) 1985-05-22 EP disclosed